Skip to content

UnitedHealth Group UNH Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Humana logo
HumanaHUM
CVS Health logo
CVS HealthCVS
DaVita logo
DaVitaDVA
CNO Financial Group logo
CNO Financial GroupCNO
HQY
HealthEquityHQY
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$111.72B+2.0%
Gross profit$98.9B+1.8%
Operating income$9.0B-1.4%
Net income$6.3B-0.2%
EPS (diluted)$6.90+0.7%

Balance sheet

See full
Cash & equivalents$28.0B-8.8%
Total debt$77.9B-4.1%
Total equity$103.90B+3.1%
Total assets$312.64B+0.9%

Cash flow

See full
Operating cash flow$8.9B+63.3%
CapEx$763.0M-15.0%
Free cash flow$8.1B+78.8%

Valuation

See full
Market cap$377.45B+40.7%
Enterprise value$427.37B+34.2%
P/E31.3×+18.7×
P/S0.8×+0.2×

Profitability

See full
Gross margin88.6%+0.4pp
Operating margin4.2%-4.0pp
Net margin2.7%-2.7pp
FCF margin4.4%-1.7pp

Returns & leverage

See full
Return on equity11.8%-11.1pp
Debt / equity0.8×-0.1×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by UnitedHealth Group in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: UnitedHealth Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about UnitedHealth Group's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UnitedHealth Group's common stock, shares issued (in shares)?
UnitedHealth Group (UNH) reported common stock, shares issued (in shares) of $908M in Q1 2026.
How has UnitedHealth Group's common stock, shares issued (in shares) changed year-over-year?
UnitedHealth Group's common stock, shares issued (in shares) decreased by 0.2% year-over-year, from $910M to $908M.
What is the long-term trend for UnitedHealth Group's common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), UnitedHealth Group's common stock, shares issued (in shares) has grown at a -0.9% compound annual growth rate (CAGR), from $946M to $906M.